Weight Off-loading Training, Cardiovascular Indices, Diabetes

NCT ID: NCT06974422

Last Updated: 2025-05-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-08-01

Study Completion Date

2025-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aims: To evaluate the effectiveness of partial weight-bearing during aerobic exercise training on cardiovascular disease risk and peripheral vascular function in patients with type 2 diabetes mellitus.

Study design: A Randomized controlled study was conducted in the outpatient rehabilitation unit.

Population: Forty-six participants (age 60 -70) with type 2 diabetes mellitus were recruited and randomly allocated into three groups: group A (100% weight-bearing; n=16), group B (75% weight-bearing; n=16), and group C (control group; n=14).

Methods: The 2 study groups A and B, received three sessions per week of moderate intensity (60-75% heart rate reserve) aerobic exercise training, for 12 weeks, 50-60 minutes session duration (including warm-up and cool-down), on the antigravity treadmill. The cardiovascular disease risk (evaluated using the Atherosclerotic cardiovascular disease risk estimator plus tool) and peripheral vascular function (presented by ankle-brachial pressure index, calculated by subdividing the ankle systolic blood pressure by the brachial systolic blood pressure) are the main study outcomes. Variables were evaluated pre-study and post-study. Ethical concepts and institutional regulations were adhered during the study. Data were described as mean and standard deviation. Paired samples t-test and one-way ANOVA were used to test within and between-subjects assumptions, respectively, considering p\< 0.05 as the significance level.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Diabetes mellitus (DM) continues as a global alarming epidemic, with an increasingly growing health burden and complications across all socioeconomic levels. Type 2 diabetes mellitus (T2DM) is associated with wide peripheral vascular complications, manifested in deteriorated lower limb blood pressure and vascular endothelial dysfunction. Prevalence of peripheral vascular disorder varies with T2DM duration, ranging from 1.2% in newly discovered T2DM cases, to about 12.5% (after 18 years of T2DM affection), and reaches 20-30% in some reports.

The abnormally increased cardiovascular disease CVD (either through traditional risk factors or direct diabetes effects) is expected to continue rising alongside DM. Adequate management for DM and associated CVD risk factors is essential to ameliorate the progression of DM and CVD.

Being active is beneficial in alleviating the peripheral vascular disease burden in patients with disturbed peripheral vascular function. Supervised treadmill exercise training can improve functional performance in patients with peripheral arterial disorders. Increasing patients' activity level is a cornerstone item in patients with T2DM rehabilitation programs.

Patients may be challenged by the disease-related pathophysiological changes and treatment requirements. The hallmark of inactivity status that dominates in patients with T2DM negatively impacts their performance during weight-bearing activities. The existence of pain, peripheral vascular disturbances, abnormally increased and unequally distributed plantar stress, all limit patients' participation and compliance with the full weight-bearing training programs.

Introducing the well-controlled partial weight-bearing through the lower body positive pressure technology during exercise training programs augments patients' active participation, minimizes weight-bearing related musculoskeletal limitations, while maintaining normal locomotion dynamics and training-related physiological responses.

Conflicts arise regarding the benefits of full and partial weight-bearing exercise training for patients with T2DM. Previous studies investigated the effects of modulating the weight-bearing status during aerobic exercise training on different health aspects and concluded conflicting results. Quite recently published studies reported the safety and efficacy of the partial weight-bearing AET training in improving the T2DM-related musculoskeletal constraints.

To our knowledge, this study is the first to investigate the effects of partial weight bearing during AET on cardiovascular variables in patients with T2DM. The objectives of this study were to evaluate the effectiveness of partial weight off-loading during aerobic exercise training, using the antigravity treadmill, on the cardiovascular disease risk and the peripheral vascular health (presented by the ankle-brachial pressure index) in patients with T2DM.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Disease, Diabetes Mellitus Type 2 Peripheral Vascular Disorder Due to Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental Group-1 (group-A; 0% weight off-loading)

This group (100% weight-bearing group) received three sessions per week of moderate-intensity (60-75% heart rate reserve) aerobic exercise training, for 12 weeks, 50-60 minutes' session duration (including warm-up and cool-down), on the antigravity treadmill. Participants also received regular oral anti-diabetic medications.

Group Type ACTIVE_COMPARATOR

Full weight bearing during aerobic exercise training

Intervention Type BEHAVIORAL

Full weight bearing (100% weight loading, 0% weight support) during moderate intensity aerobic exercise training on the antigravity treadmill.

Experimental Group-2 (group-B; 25% weight off-loading)

This group (27% weight-bearing group) received three sessions per week of moderate-intensity (60-75% heart rate reserve) aerobic exercise training, for 12 weeks, 50-60 minutes' session duration (including warm-up and cool-down), on the antigravity treadmill. Participants also received regular oral anti-diabetic medications.

Group Type EXPERIMENTAL

Partial weight bearing during aerobic exercise training

Intervention Type BEHAVIORAL

Partial weight bearing (25% weight support) during the moderate intensity aerobic exercise training on the antigravity treadmill

Control group (Group; Non-exercising group)

The control group participants received the same pre- and post-study evaluations as those for the study groups A and B, but did not participate in any aerobic exercise training on the antigravity treadmill. Participants only received regular oral anti-diabetic medications.

Group Type OTHER

Regular oral anti-diabetic medications.

Intervention Type DRUG

Participants in the control group (group C) received regular oral anti-diabetic medications.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Partial weight bearing during aerobic exercise training

Partial weight bearing (25% weight support) during the moderate intensity aerobic exercise training on the antigravity treadmill

Intervention Type BEHAVIORAL

Full weight bearing during aerobic exercise training

Full weight bearing (100% weight loading, 0% weight support) during moderate intensity aerobic exercise training on the antigravity treadmill.

Intervention Type BEHAVIORAL

Regular oral anti-diabetic medications.

Participants in the control group (group C) received regular oral anti-diabetic medications.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Antigravity treadmill aerobic exercise training partial weight offloading during aerobic exercise training

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Type 2 diabetes mellitus patients with 0.6\< ankle brachial index ≤ 0.9, treated only with oral hypoglycemic medications (Biguanide or Sulfonylureas + Biguanide), oral anti-diabetic drugs combination, with stable pharmacological treatment for at least 3 months before the study.
* Cognitively competent patients, able to walk independently with or without walking aids, assuming a Sedentary lifestyle (less than 30 minutes daily activity) during the last 6 months.
* Type 2 diabetes mellitus for more than 10 years, with glycosylated hemoglobin (HbA1c% %) level more than 7%, and fasting glucose level more than 7.0 mmol/L.
* Age range from 60 to 70 years, with normal/ accepted nutritional status (Mini Nutritional Assessment score more than 11).

Exclusion Criteria

* The following condition resulted in the exclusion of the patients from the study at the initial screening stage:
* Patients with Type 1 diabetes, younger than 60 or older than 70 years.
* Participation in any previous training program or diet regimen within the last 6 months.
* Patients with disturbed nutritional status (Mini Nutritional Assessment score less than 11).
* Serious musculoskeletal or cardiopulmonary disorders that can affect patient safety or the study results.
Minimum Eligible Age

60 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Umm Al-Qura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ashraf Abdelaal

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ASHRAF AM ABDELAAL, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Associate Professor

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Umm Al-Qura University

Mecca, , Saudi Arabia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Saudi Arabia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SNEZ070525

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.